|
Masahiro Fujita, M.D.
Dr. Masahiro Fujita is a Staff Scientist for the PET Imaging
Section, Molecular Imaging Branch at the National Institute of Mental Health
(NIMH). Dr. Fujita received MD in 1987 and PhD in 1992 both from Osaka
University Graduate School of Medicine, Japan. He also completed residency of
radiology in 1993 and nuclear medicine in 1995, both at Osaka University
Hospital, Japan. During these periods, Dr. Fujita had training in both in vitro
neuroanatomical experiments and neuroreceptor imaging in addition to clinical
nuclear medicine and radiology. In 1995, Dr. Fujita began further post-doctoral
training in neuroreceptor imaging at the Department of Psychiatry, Yale
University School of Medicine, and became an Assistant Professor in 1999. He
joined NIMH in 2002.
Dr. Fujita specializes in evaluation of new
positron emission tomography and single photon emission computed tomography
radioligands to image brain neurotransmission systems. For the evaluation, he
uses rodents, nonhuman primates, and human subjects and applies both in vivo
and in vitro techniques. In vivo techniques include pharmacological drug
challenge studies and pharmacokinetic analyses. In vitro techniques include
autoradiography and homogenate binding assays. In addition to evaluation of new
radioligands using normal animals and human subjects, he explorers application to
psychiatric and neurological disorders by preparing rodent models and also
applying receptor imaging techniques to patients with these disorders. Targets
of imaging are not limited to neurotransmitter receptors and transporters. Release
of neurotransmitters and intracellular signal transduction systems are also targeted,
which have not been explored as much as receptors and transporters. |
|